Chronic diseases and smoking in SARS-CoV-2 infection in Pinar del Rio

Authors

Keywords:

Covid-19, SARS-COV-2, CORONAVIRUS, CHRONIC DISEASE, SMOKING.

Abstract

Introduction: the world deals with a new pandemic because of SARS-CoV-2 outbreak initiated in Wuhan, China in December 2019. Host genetic differences and risk factors such as: personal history, lifestyles and environmental factors may contribute to the marked inter-individual clinical variability in COVID-19.

Objective: to identify personal pathological history (chronic diseases and smoking) associated with SARS-CoV-2 infection.

Methods: analytical, observational study of cases and controls in Pinar del Rio in the period from March 2020 to March 2021. Personal history of chronic diseases and smoking as an environmental factor were explored.

Results: personal pathological history of allergies and asthma constituted risk factors to develop symptoms. History of active smoking is presented as a risk factor for infection.

Conclusions: the contribution of personal pathological history (allergy and asthma) and environmental (active smoking) to SARS-CoV-2 infection and to the development of symptoms in COVID-19 patients in Pinar del Rio is confirmed.

 

Downloads

Download data is not yet available.

References

1. Cajamarca Baron J, Guavita Navarro D, Buitrago Bohorquez J, Gallego Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) en pacientes con algún grado de inmunosupresión. Reumatol Clínica [Internet]. 2021 [citado: 21/10/2020]; 17(7): 408-419. Disponible en: https://doi.org/10.1016/j.reuma.2020.08.004

2. Min Z, Jun C, Fu F, Shu Q, Hu Y, Chun C, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr [Internet]. 2020 [citado: 15/03/2020]; 16: 240-246. Disponible en: https://doi.org/10.1007/s12519-020-00345-5

3. Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS- CoV-2 and COVID-19 susceptibility and severity. Immunol Rev [Internet]. 2020 [citado: 21/10/2020]; 296(1): 205–19. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404857/

4. Hanif M, Haider MA, Xi Q, Ali MJ, Ahmed MU. A Review of the Risk Factors Associated With Poor Outcomes in Patients With Coronavirus Disease 2019. Cureus [Internet]. 2020 [citado: 21/10/2020]; 12(9): e10350. Disponible en: https://doi.org/10.7759/cureus.10350%0A

5. Radzikowska U, Traidl-hoffmann C, Akdis C, Sokolowska M, Au N, Ca A. Distribution of ACE2, CD147, CD26 and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy [Internet]. 2020 [citado: 21/10/2020]; 75(11): 2829–45. Disponible en: https://doi.org/10.1111/all.14429

6. Rosas Arango SM, Ángel-caraza, Del Ángel Caraza J, Soriano Vargas E. Infección por COVID-19 , una mirada a los factores ambientales relacionados con la pandemia. NOVA [Internet]. 2020 [citado: 21/10/2020]; 18(35): 101–5. Disponible en: https://doi.org/10.22490/24629448.4193

7. Piñera Castro HJ, Ruiz Gonzalez LA. Implicaciones del tabaquismo en el contexto de la COVID-19. Rev cub med Mil [Internet]. 2022 [citado: 10/01/2022]; 51(1): e02201457. Disponible en: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/1457/1014

8. Wang, Dawei, Bo Hu, Chang Hu FZ, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020 [citado: 21/10/2020]; 323(11): 1061-1069. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042881/

9. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the Novel Wuhan Coronavirus (COVID-19) infection: a systematic review and meta-analysis. J Inter Infect Dis [Internet]. 2020 [citado: 21/10/2020]; 94(10): 91–5. Disponible en: https://www.sciencedirect.com/science/article/pii/S1201971220301363?via%3Dihub

10. Costa de Lucena T, Fernandes da Silva Santos A, de Albuquerque Borborema ME, de Azevedo Silva J. Mechanism of in fl ammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020 [citado: 21/10/2020]; 14(4): 597–600. Disponible en: https://doi.org/10.1016/j.dsx.2020.05.025

11. Pérez Caballero MD, León Alvárez JL, Dueñas Herrera A, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertención. Rev Cuba med [Internet]. 2017 [citado: 21/10/2020]; 56(4): 242–231. Disponible en: http://scielo.sld.cu.php

12. Zhang JJ, Dong X, Cao Y, Yuan Y, Yang Y, Yan Y. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy [Internet]. 2020 [citado: 21/10/2020]; 75(7): 1730–41. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32077115/

13. Ravichandran B, Grimm D, Infanger M, Wehland M, Kopp S. SARS-CoV-2 and hypertension. Physiological Reports [Internet]. 2021 [citado: 06/10/2021]; 9(11): e14800. Disponible en: https://doi.org/10.14814/phy2.14800

14. Li J, Liu HH, Yin XD, Li C. COVID 19 illness and autoimmune diseases: recent insights.pdf. Inflamm Res Off J Eur Histamine Res Soc [Internet]. 2021 [citado: 06/10/2021]; 70(4): 407–28. Disponible en: https://doi.org/10.1007/s00011-021-01446-1

15. Zen M, Fuzzi E, Astorri D, et al. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: a cross-sectional study on 916 patients. J Autoimmun [Internet]. 2020 [citado: 06/10/2021]; 112: 102502. Disponible en: https://doi.org/10.1016/j.jaut.2020.102502

16. Michael RE, Stronf K, Cameron A, Walton RP, Jackson DJ, Johoston SL, et al. Viral Infections in allergy and immunology: How allergic inflamatio influences viral infections and illness. J Allergy Clin Immunol [Internet]. 2017 [citado: 06/10/2021]; 140(4): 909–20. Disponible en: https://doi.org/10.1016/j.jaci.2017.07.025

17. L AF. Para la salud, debates científicos oportunos [Internet]. Granma [Internet] 2017 [citado: 06/10/2021]; (2): 2–3. Disponible en: https://www.granma.cu/todo-salud/2017-10-06/para-la-salud-dos-debates-cientificos-oportunos-06-10-2017-00-10-23

18. Orraca O, Navarro E, Quintero W, Blanco TM, Rodríguez LR. Frecuencia de infecciones respiratorias agudas en niños y adolescentes con asma de la provincia de Pinar del Río. MEDISAN [Internet]. 2018 [citado: 06/10/2021]; 22(1): 33–9. Disponible en: https://scielo.sld.cu/scielo.php?script=sci-arttext&pid=S1029-30192018000100005&Ing=es

19. Papadopoulos NG , Xepapadaki P. Papel de las infecciones virales en el asma. Salud(i)Ciencia [Internet]. 2017 [citado: 06/10/2021]; 22(6): 545–51. Disponible en: https://www.dx.doi.org/10.21840/siic/75594

20. Licari A, Votto M, Brambilla I, et al. Allergy and asthma in children and adolescent during the COVID-19 ioutbreak: What we know and how we could prevent allergy and asthma flares. Allergy [Internet]. 2020 [citado: 06/10/2021]; 75(9): 2402–5. Disponible en: https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/es/covidwho-276469

21. Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist ’ s perspective. J ALLERGY CLIN IMMUNOL [Internet]. 2020 [citado: 06/10/2021]; 146(2): 285–99. Disponible en: https://doi.org/10.1016/j.jaci.2020.05.033

22. OMS. Declaración de la OMS: consumo de tabaco y COVID-19 [Internet]. 2020 [citado: 06/10/2021]. Disponible en: http://www.who.int/es/news/item/11-05-2020-who-statement-tobacco-use-and-covid-19

23. Garufi Giovanna, Carbognin L, Orlandi A, Tortora G BE. Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- related pneumonia: The unsolved paradox behind the evidence. Eur J Intern Med [Internet]. 2020 [citado: 10/01/2022]; 77(4): 121–2. Disponible en: https://doi.org/10.1016/j.ejim.2020.04.042

24. Fernández Rúa JM. Nueva amenaza del tabaco en pacientes con COVID-19. Biotech Magazine [Internet]. 2021 [citado: 10/01/2022]; 3: 1–3. Disponible en: https://biotechmagazineandnews.com/nueva-amenaza-del-tabaco-en-pacientes-de-covid-19/

Downloads

Published

2022-06-15

How to Cite

1.
Valdés Lanza L, Orraca Castillo O, Lardoeyt-Ferrer R, Orraca-Castillo M, Martínez-Carmona Y, Miló-Valdés CA. Chronic diseases and smoking in SARS-CoV-2 infection in Pinar del Rio. Rev Ciencias Médicas [Internet]. 2022 Jun. 15 [cited 2025 Aug. 13];26(3):e5511. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5511

Issue

Vol. 26 No. 3 (2022)

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/